Vaccinex Stock Performance
| VCNX Stock | USD 1.37 0.21 18.10% |
Vaccinex holds a performance score of 14 on a scale of zero to a hundred. The entity has a beta of -1.77, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Vaccinex are expected to decrease by larger amounts. On the other hand, during market turmoil, Vaccinex is expected to outperform it. Use Vaccinex rate of daily change, relative strength index, as well as the relationship between the semi variance and sortino ratio , to analyze future returns on Vaccinex.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vaccinex are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Vaccinex showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Vaccinex |
Vaccinex Relative Risk vs. Return Landscape
If you would invest 51.00 in Vaccinex on November 2, 2025 and sell it today you would earn a total of 86.00 from holding Vaccinex or generate 168.63% return on investment over 90 days. Vaccinex is currently generating 2.9648% in daily expected returns and assumes 16.6415% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Vaccinex, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vaccinex Target Price Odds to finish over Current Price
The tendency of Vaccinex Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.37 | 90 days | 1.37 | roughly 2.08 |
Based on a normal probability distribution, the odds of Vaccinex to move above the current price in 90 days from now is roughly 2.08 (This Vaccinex probability density function shows the probability of Vaccinex Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Vaccinex has a beta of -1.77. This entails as returns on its benchmark rise, returns on holding Vaccinex are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Vaccinex is expected to outperform its benchmark. Moreover Vaccinex has an alpha of 1.7888, implying that it can generate a 1.79 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Vaccinex Price Density |
| Price |
Predictive Modules for Vaccinex
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vaccinex. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vaccinex Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vaccinex is not an exception. The market had few large corrections towards the Vaccinex's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vaccinex, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vaccinex within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.79 | |
β | Beta against Dow Jones | -1.77 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | 0.10 |
Vaccinex Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vaccinex for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vaccinex can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vaccinex is way too risky over 90 days horizon | |
| Vaccinex may become a speculative penny stock | |
| Vaccinex appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 570 K. Net Loss for the year was (20.25 M) with loss before overhead, payroll, taxes, and interest of (13.7 M). | |
| Vaccinex currently holds about 11.4 M in cash with (17.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. |
Vaccinex Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vaccinex Pink Sheet often depends not only on the future outlook of the current and potential Vaccinex's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaccinex's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 463.6 K | |
| Cash And Short Term Investments | 1.5 M |
Vaccinex Fundamentals Growth
Vaccinex Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vaccinex, and Vaccinex fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaccinex Pink Sheet performance.
| Return On Equity | -7.59 | |||
| Return On Asset | -4.96 | |||
| Current Valuation | 1.59 M | |||
| Shares Outstanding | 2.68 M | |||
| Price To Book | 7.34 X | |||
| Price To Sales | 4.34 X | |||
| Revenue | 570 K | |||
| EBITDA | (19.75 M) | |||
| Cash And Equivalents | 11.4 M | |||
| Cash Per Share | 0.27 X | |||
| Total Debt | 247 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | (2.59) X | |||
| Cash Flow From Operations | (17.23 M) | |||
| Earnings Per Share | 7.42 X | |||
| Total Asset | 3.63 M | |||
| Retained Earnings | (339.93 M) | |||
About Vaccinex Performance
Evaluating Vaccinex's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Vaccinex has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vaccinex has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.Things to note about Vaccinex performance evaluation
Checking the ongoing alerts about Vaccinex for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vaccinex help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vaccinex is way too risky over 90 days horizon | |
| Vaccinex may become a speculative penny stock | |
| Vaccinex appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 570 K. Net Loss for the year was (20.25 M) with loss before overhead, payroll, taxes, and interest of (13.7 M). | |
| Vaccinex currently holds about 11.4 M in cash with (17.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. |
- Analyzing Vaccinex's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaccinex's stock is overvalued or undervalued compared to its peers.
- Examining Vaccinex's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vaccinex's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaccinex's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vaccinex's pink sheet. These opinions can provide insight into Vaccinex's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Vaccinex Pink Sheet Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.